High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors-Reference-Cited by-同舟云学术

High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors

Published:2015-09-17 Issue:10 Volume:17 Page:641-652
ISSN:2156-8952
Container-title:ACS Combinatorial Science
language:en
Short-container-title:ACS Comb. Sci.

Author:

He Shanshan¹,Jain Prashi,Lin Billy¹,Ferrer Marc²,Hu Zongyi¹,Southall Noel²,Hu Xin²,Zheng Wei²,Neuenswander Benjamin,Cho Chul-Hee,Chen Yu,Worlikar Shilpa A.,Aubé Jeffrey,Larock Richard C.,Schoenen Frank J.,Marugan Juan J.²,Liang T. Jake¹,Frankowski Kevin J.

Affiliation:

1. Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States

2. NIH Chemical Genomics Center, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States

Funder

National Center for Research Resources

National Human Genome Research Institute

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acscombsci.5b00101

Reference17 articles.

1. Recent advances and future directions in the management of hepatitis C infections